Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 1c, Lowers FY Guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.81, $0.01 better than the analyst estimate of $1.80. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.96 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2021 EPS of $7.32-$7.47, versus the consensus of $7.70.

• 2021 reported revenue growth 11.3% - 12.5%

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Green Dot and CommerceOne shareholders approve acquisition deal